Diamond Biotechnology Co., Ltd.(TW:6815)
NT$19.00-0.90 (-4.52%)
TW:6815
Diamond Biotechnology Co., Ltd. Revenue
NT$19.00
At close:-0.90 (-4.52%)
Diamond Biotechnology Co., Ltd. (6815) Revenue
Diamond Biotechnology Co., Ltd. Revenue
Diamond Biotechnology Co., Ltd. had a revenue of 280.74M in the quarter ending Jun 30, 2026, with 52.66%. This bring the company's revenue in the last twelve months to 464.63M, Decreased 7.35%. In the fiscal year ending Dec 31, 2025, Diamond Biotechnology Co., Ltd. had annual revenue of 501.49M with -34.72% growth.
- Revenue (ttm)
- 464.63M
- Revenue Growth
- -33.45%
- P/S Ratio
- 1.58
- Revenue/Employee
- TWD 11,144,311
- Employees
- 45
- Market Cap
- TWD 790.14M
Revenue Chart
Diamond Biotechnology Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 501.49M | -266.76M | -34.72% |
| Dec 31, 2024 | 768.25M | 152.16M | 24.70% |
| Dec 31, 2023 | 616.10M | 181.25M | 41.68% |
| Dec 31, 2022 | 434.84M | 39.64M | 10.03% |
| Dec 31, 2021 | 395.20M | 88.81M | 28.99% |
| Dec 31, 2020 | 306.39M | 38.04M | 14.17% |
| Dec 31, 2019 | 268.35M | 41.48M | 18.28% |
| Dec 31, 2018 | 226.88M | 34.29M | 17.80% |
| Dec 31, 2017 | 192.59M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.